Molecular Partners AG (CHIX:MOLNz) Stock News, Headlines & Updates
Molecular Partners AG Stock News from GuruFocus
- 1
Jun 17, 2024
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
Marketwired • 12:00am
Jun 14, 2024
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
Marketwired • 12:00am
Jun 11, 2024
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
Marketwired • 12:00am
Jun 01, 2024
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
GlobeNewswire • 11:00am
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
Marketwired • 7:00am
May 16, 2024
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
Marketwired • 3:00pm
Apr 29, 2024
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of ActionÂ
Marketwired • 10:00am
Apr 19, 2024
Life Science Cares Launches in Switzerland
GlobeNewswire • 11:00am
Life Science Cares Launches in Switzerland
Marketwired • 11:00am
Apr 17, 2024
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Marketwired • 11:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news